Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.
Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA.
Carbone DP, et al. Among authors: top le.
J Clin Oncol. 2005 Aug 1;23(22):5099-107. doi: 10.1200/JCO.2005.03.158. Epub 2005 Jun 27.
J Clin Oncol. 2005.
PMID: 15983396
Free article.
Clinical Trial.